Transcranial Magnetic Stimulation: From an innovative research tool to a new therapy and beyond
Transcranial Magnetic Stimulation · 2024
DOI: 10.1016/j.transm.2024.100003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transcranial Magnetic Stimulation, 2024. Verfasst von Mark S. George. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brain and Behavior Research Foundation, National Alliance for Research on Schizophrenia and Depression, Medical University of South Carolina.
Abstract (Originalsprache)
Launching a journal devoted to TMS is a critical next step in further developing TMS as a research tool and therapy. I strongly support and am excited at the potential and prospects for what this society-based journal can do for the field of TMS and brain stimulation in general. Sixteen years ago Professor Harold Sackeim and I launched the journal Brain Stimulation with the support of Elsevier publisher Josh Spieler (who is also involved in launching this journal) (Sackeim & George, 2008). At that time, few people anticipated the field’s growth and evolution into a significant branch of neuroscience tools and therapies.
Förderung
- Brain and Behavior Research Foundation
- National Alliance for Research on Schizophrenia and Depression
- Medical University of South Carolina
- National Institutes of Health
Zitieren
APA
George, M. S. (2024). Transcranial Magnetic Stimulation: From an innovative research tool to a new therapy and beyond. Transcranial Magnetic Stimulation. https://doi.org/10.1016/j.transm.2024.100003
Vancouver
George MS. Transcranial Magnetic Stimulation: From an innovative research tool to a new therapy and beyond. Transcranial Magnetic Stimulation. 2024. doi:10.1016/j.transm.2024.100003
BibTeX
@article{George2024,
author = {George, Mark S.},
title = {Transcranial Magnetic Stimulation: From an innovative research tool to a new therapy and beyond},
journal = {Transcranial Magnetic Stimulation},
year = {2024},
doi = {10.1016/j.transm.2024.100003}
}
EUVIMED